UBS Group AG - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 107 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$175,000
-65.5%
364,785
-3.6%
0.00%
Q1 2019$507,000
+13.9%
378,308
-4.0%
0.00%
Q4 2018$445,000
-43.3%
394,141
+38.6%
0.00%
Q3 2018$785,000
+13.9%
284,351
+47.4%
0.00%
Q2 2018$689,000
-39.0%
192,871
-47.6%
0.00%
Q1 2018$1,130,000
+22500.0%
367,901
+56326.5%
0.00%
Q2 2017$5,000
-96.9%
652
-96.2%
0.00%
Q1 2017$159,000
+133.8%
17,269
+2.3%
0.00%
Q4 2016$68,000
+183.3%
16,882
+172.6%
0.00%
Q3 2016$24,000
+1100.0%
6,193
+1425.4%
0.00%
Q2 2016$2,000
-95.8%
406
-96.1%
0.00%
Q1 2016$48,000
-84.8%
10,500
-66.6%
0.00%
Q4 2015$316,000
+4.6%
31,435
-22.2%
0.00%
Q3 2015$302,000
-83.5%
40,411
+4.8%
0.00%
-100.0%
Q2 2015$1,830,000
+7.3%
38,567
-17.2%
0.00%0.0%
Q1 2015$1,706,000
+180.1%
46,553
+203.5%
0.00%
Q4 2014$609,00015,3380.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2015
NameSharesValueWeighting ↓
683 Capital Management, LLC 600,000$2,142,0000.14%
Tekla Capital Management LLC 859,322$3,068,0000.12%
DOW CHEMICAL CO /DE/ 65,000$232,0000.08%
Candriam S.C.A. 495,613$1,769,0000.03%
A.R.T. Advisors, LLC 174,335$622,0000.02%
Baker Brothers Advisors 935,000$3,338,0000.02%
FLAGSHIP HARBOR ADVISORS, LLC 29,400$104,0000.02%
Alambic Investment Management, L.P. 17,804$64,0000.02%
Teton Advisors, Inc. 44,000$157,0000.01%
Man Group plc 737,715$2,634,0000.01%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders